NASDAQ: RIGLRigel Pharmaceuticals Revenue
Rigel Pharmaceuticals revenue was $299.77M for the trailing 12 months ending Mar 31, 2026, with 863.3% growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $58.8M, down 15.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RIGL annual revenue was $294.3M, with 64.1% growth year-over-year.
RIGL past revenue growth
How has RIGL's revenue growth performed historically?
Company
47.61%
Industry
259.09%
Market
37.86%
RIGL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RIGL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RIGL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
RIGL revenue history
Current Revenue
$299.8M
Current Earnings
$364.2M
Current Profit Margin
121.5%
Be the first to know when RIGL announces revenue.
RIGL Revenue History By Year
| RIGL Yearly Revenue | RIGL Revenue | RIGL Change | RIGL Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $294.28M | $115.00M | +64.15% |
| 2024-12-31 | $179.28M | $62.40M | +53.38% |
| 2023-12-31 | $116.88M | -$3.36M | -2.79% |
| 2022-12-31 | $120.24M | -$28.99M | -19.43% |
| 2021-12-31 | $149.24M | $40.62M | +37.39% |
| 2020-12-31 | $108.62M | $49.33M | +83.21% |
| 2019-12-31 | $59.29M | $14.78M | +33.20% |
| 2018-12-31 | $44.51M | $40.03M | +892.62% |
| 2017-12-31 | $4.48M | -$15.90M | -78.00% |
| 2016-12-31 | $20.38M | -$8.51M | -29.46% |
| 2015-12-31 | $28.90M | $20.65M | +250.24% |
| 2014-12-31 | $8.25M | $1.10M | +15.38% |
| 2013-12-31 | $7.15M | $4.90M | +217.78% |
| 2012-12-31 | $2.25M | -$2.50M | -52.63% |
| 2011-12-31 | $4.75M | -$120.25M | -96.20% |
| 2010-12-31 | $125.00M | $124.25M | +16,566.67% |
| 2009-12-31 | $750.00k | N/A | N/A |
| 2008-12-31 | $0.00 | -$12.60M | -100.00% |
| 2007-12-31 | $12.60M | -$20.87M | -62.36% |
| 2006-12-31 | $33.47M | $16.95M | +102.55% |
| 2005-12-31 | $16.53M | $11.79M | +249.17% |
| 2004-12-31 | $4.73M | -$6.32M | -57.19% |
| 2003-12-31 | $11.06M | -$4.73M | -29.98% |
| 2002-12-31 | $15.79M | $485.00k | +3.17% |
| 2001-12-31 | $15.30M | $2.09M | +15.77% |
| 2000-12-31 | $13.22M | $4.23M | +47.13% |
| 1999-12-31 | $8.98M | $8.96M | +31,985.71% |
| 1998-12-31 | $28.00k | N/A | N/A |
| 1997-12-31 | $0.00 | N/A | N/A |
Rigel Pharmaceuticals Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.